Armata Pharmaceuticals, Inc. 公布的第一季度业绩显示,公司净亏损大幅扩大至1.153亿美元,折合每股亏损3.16美元。这一数字与去年同期的表现形成了鲜明对比,当时公司净亏损为650万美元,每股亏损0.18美元。
Armata Pharmaceuticals, Inc. 公布的第一季度业绩显示,公司净亏损大幅扩大至1.153亿美元,折合每股亏损3.16美元。这一数字与去年同期的表现形成了鲜明对比,当时公司净亏损为650万美元,每股亏损0.18美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.